Product image of Linezolid Panpharma (Linezolid) supplied by GNH India

Linezolid Panpharma

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Panpharma (Linezolid)

Linezolid, the active ingredient in Linezolid Panpharma, is an oxazolidinone presented as an injectable solution for intravenous use. It treats infections caused by susceptible Gram‑positive bacteria, including MRSA and VRE, in hospitalized patients.

GNH India supplies Linezolid Panpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Panmedica

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is indicated for serious infections caused by Gram‑positive bacteria, acting on resistant and susceptible strains.

  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: provides effective bacteriostatic activity against resistant Staphylococcus aureus.
  • Vancomycin‑resistant Enterococcus (VRE) infections: treats infections caused by vancomycin‑resistant Enterococcus species.
  • Community‑acquired and hospital‑acquired pneumonia: covers typical Gram‑positive pathogens in lower respiratory tract infections.
  • Skin and soft‑tissue infections: resolves complicated SSTIs caused by susceptible organisms.
  • Complicated infections caused by susceptible Gram‑positive bacteria: offers broad coverage for serious systemic infections.

How It Works

  • Linezolid binds to the 50S ribosomal subunit of susceptible bacteria, preventing the formation of the initiation complex required for protein synthesis. This inhibition halts bacterial growth, producing a bacteriostatic effect against Gram‑positive organisms, including resistant strains such as MRSA and VRE.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: transient gastrointestinal upset.
  • Diarrhea: loose stools, often self‑limiting.
  • Headache: mild to moderate intensity.
  • Vomiting: occasional emesis.
  • Metallic taste: altered taste perception.
  • Rash: mild skin irritation.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count.
  • Anemia: reduced red blood cell levels.
  • Peripheral neuropathy: nerve damage causing tingling or numbness.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Lactic acidosis: rare metabolic disturbance.
  • Optic neuropathy: potential vision changes.

Precautions & Warnings

Use of Linezolid requires careful monitoring and specific safety measures.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: assess liver enzymes regularly.
  • Concomitant serotonergic agents: avoid due to risk of serotonin syndrome.
  • Myelosuppression: perform routine blood count monitoring.
  • Pregnancy Category B: prescribe only when benefit outweighs potential risk.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Linezolid interacts with several drug classes; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): can precipitate serotonin toxicity.
  • Rifampin: induces metabolism, reducing linezolid exposure.
  • Warfarin: may increase anticoagulant effect and bleeding risk.
  • Phenylpropanolamine: potentiates hypertensive reactions.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased bleeding tendency.
  • Diuretics: additive hypotensive effect.
  • Carbamazepine: may lower linezolid concentrations.
  • Oral contraceptives: possible reduction in efficacy.
  • Other bacteriostatic antibiotics (e.g., chloramphenicol): potential antagonism.

Frequently Asked Questions

Linezolid Panpharma is used to treat serious infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA), vancomycin‑resistant Enterococcus (VRE), community‑acquired and hospital‑acquired pneumonia, and complicated skin and soft‑tissue infections.

Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex needed for translation. This action stops bacterial growth, providing a bacteriostatic effect against Gram‑positive organisms.

The dosing regimen for Linezolid Panpharma is determined by the prescribing clinician based on the specific infection, patient characteristics, and local guidelines. The prescriber sets the appropriate dose and duration.

Linezolid is classified as Pregnancy Category B, indicating that animal studies have not shown risk but there are no adequate human studies. It should be used only if the potential benefit justifies any potential risk to the fetus. Caution is also advised during breastfeeding, and a healthcare professional should evaluate the risk‑benefit ratio.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The team then replies with pricing, availability, shipping details (including cold‑chain handling if needed) and any required import documentation.

Linezolid offers oral and intravenous options and retains activity against many resistant Gram‑positive pathogens, such as MRSA and VRE, where some beta‑lactams and glycopeptides may be ineffective. Compared with daptomycin, linezolid provides a broader safety profile for pulmonary infections, while daptomycin is not indicated for pneumonia.

Linezolid Panpharma should be stored at 2‑8 °C, kept refrigerated, protected from light, and should not be frozen or shaken. Maintain the product in its original packaging to preserve stability.

Linezolid Panpharma is supplied as an injectable solution for intravenous administration. It is administered by a healthcare professional using aseptic technique, typically via a peripheral or central venous line, according to the prescriber's instructions.

Serious risks include thrombocytopenia, anemia, peripheral neuropathy, optic neuropathy, serotonin syndrome when combined with serotonergic drugs, and rare cases of lactic acidosis. Patients should be monitored regularly for hematologic changes and neurological symptoms.

Linezolid should be avoided in patients with known hypersensitivity to linezolid or any component of the formulation. Caution is advised for individuals taking serotonergic agents, those with severe hepatic impairment, or patients with a history of myelosuppression unless benefits outweigh risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT